V. Blanchette
- Hematology top 0.2%
- Hemophilia Treatment and Research 26
- Platelet Disorders and Treatments 21
- Blood groups and transfusion 16
- Blood Coagulation and Thrombosis Mechanisms 9
- Nephrology top 2%
- Renal Diseases and Glomerulopathies 4
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Biochemistry top 5%
- Blood transfusion and management 6
-
- Immunodeficiency and Autoimmune Disorders 5
- Cited by
- HematologyNephrologyGenetics
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
V. Blanchette
55 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 2.8k
- Nephrology 375
- Genetics 394
- Biochemistry 150
- Pathology and Forensic Medicine 425
Countries citing papers authored by V. Blanchette
This map shows the geographic impact of V. Blanchette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Blanchette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Blanchette more than expected).
Fields of papers citing papers by V. Blanchette
This network shows the impact of papers produced by V. Blanchette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Blanchette. The network helps show where V. Blanchette may publish in the future.
Co-authorship network
The 25 scholars most cited alongside V. Blanchette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 20 | |
| 2 | 2011 | 15 | |
| 3 | 2011 | 17 | |
| 4 | 2007 | 15 | |
| 5 | 2006 | 82 | |
| 6 | 2005 | 16 | |
| 7 | 2002 | 1 | |
| 8 | 1999 | 6 | |
| 9 | 1998 | 26 | |
| 10 | 1998 | 6 | |
| 11 | Review of the literature on allogeneic red blood cell and plasma transfusions in children | 1997 | 6 |
| 12 | 1996 | 17 | |
| 13 | 1994 | 18 | |
| 14 | 1992 | 66 | |
| 15 | 1991 | 23 | |
| 16 | 1991 | 23 | |
| 17 | 1990 | 15 | |
| 18 | 1989 | 37 | |
| 19 | 1988 | 5 | |
| 20 | Vitamin E, sample size, and beta error. | 1980 | 1 |
About V. Blanchette
V. Blanchette is a scholar working on Hematology, Genetics, Biochemistry, Nephrology and Immunology, having authored 56 papers that have together received 3.3k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (26 papers), Platelet Disorders and Treatments (21 papers), Blood groups and transfusion (16 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Blood transfusion and management (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Renal Diseases and Glomerulopathies (4 papers). The work is most often cited by research in Hematology (2.8k citations), Nephrology (375 citations), Genetics (394 citations), Biochemistry (150 citations) and Pathology and Forensic Medicine (425 citations). V. Blanchette has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Woolf Sh, LM Aledort, JG Kelton, JB Bussel, Robert McMillan, Indira Warrier, DB Cines, JN George, Raskob Ge and A. M. Stain. Their work appears in journals such as Haemophilia, Transfusion, Blood, Journal of Thrombosis and Haemostasis and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.